Orofacial dyskinesia induced by nasal Ritalin(R) (methylphenidate) sniffing: a rare case report from Switzerland.

Related Articles

Orofacial dyskinesia induced by nasal Ritalin(R) (methylphenidate) sniffing: a rare case report from Switzerland.

Hum Exp Toxicol. 2013 Mar;32(3):332-4

Authors: Marti G, Fattinger K, Zimmermann H, Exadaktylos A

Abstract
Ritalin® (methylphenidate) is an amphetamine-like prescription stimulant commonly used in the treatment of attention deficit hyperactivity disorder in children and adults. Recently, the recreational use of Ritalin has increased, particularly among young adults. Well-known symptoms of intoxication include signs of sympathetic nervous stimulation, such as agitation, anxiety, tachycardia, hypertension, headache, tremor, and dizziness. This case report describes oral dyskinesia as a rare presentation of Ritalin intoxication, with the review of pathophysiology and some epidemiological data.

PMID: 23174746 [PubMed – indexed for MEDLINE]

via http://www.ncbi.nlm.nih.gov/pubmed/23174746?dopt=Abstract